A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 17 490 KRW -3.53% Market Closed
Market Cap: 393.4B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+29%
Revenue
Forecast
+1%
Operating Income
Forecast
-11%
Net Income
Forecast
-15%

Wall Street
Price Targets

Price Targets Summary
AprilBio Co Ltd

Wall Street analysts forecast AprilBio Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 35 700 KRW with a low forecast of 35 350 KRW and a high forecast of 36 750 KRW.

Lowest Forecast
Wall Street Target
35 350 KRW
102% Upside
Average Forecast
Wall Street Target
35 700 KRW
104% Upside
Highest Forecast
Wall Street Target
36 750 KRW
110% Upside
Lowest
Price Target
35 350 KRW
102% Upside
Average
Price Target
35 700 KRW
104% Upside
Highest
Price Target
36 750 KRW
110% Upside
AprilBio Co Ltd Competitors:
Price Targets
IONS
Ionis Pharmaceuticals Inc
65% Upside
K
4584
Kidswell Bio Corporation
51% Upside
ZNTL
Zentalis Pharmaceuticals Inc
346% Upside
B
377740
BioNote Inc
13% Upside
IONS
Ionis Pharmaceuticals Inc
65% Upside
K
4584
Kidswell Bio Corporation
51% Upside
ZNTL
Zentalis Pharmaceuticals Inc
346% Upside
B
377740
BioNote Inc
13% Upside
ALT
Altimmune Inc
222% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
60% Downside
AGIO
Agios Pharmaceuticals Inc
63% Upside
LEGN
Legend Biotech Corp
112% Upside

Revenue
Forecast

Revenue Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's revenue for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's operating income for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's net income for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AprilBio Co Ltd's stock price target?
Price Target
35 700 KRW

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 35 700 KRW with a low forecast of 35 350 KRW and a high forecast of 36 750 KRW.

What is AprilBio Co Ltd's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of AprilBio Co Ltd's revenue for the next 3 years is 26%.

What is AprilBio Co Ltd's Operating Income forecast?
Projected CAGR
29%

The compound annual growth rate of AprilBio Co Ltd's operating income for the next 3 years is 29%.

What is AprilBio Co Ltd's Net Income forecast?
Projected CAGR
17%

The compound annual growth rate of AprilBio Co Ltd's net income for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.